Skip to main content
SpringerLink
Log in

Pharmacokinetic changes during pregnancy and postpartum is of minor importance for most drugs

  • Practical Issues and Updates
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Loebstein R, Lalkin A, Koren G. Pharmacokinetic changes during pregnancy and their clinical relevance. Clin Pharmacokinet 1997 Nov; 33(5): 328–43

    Article  PubMed  CAS  Google Scholar 

  2. Koren G, Bologa M, Pastuszak A. The way women perceive a teratogenic risk: the decision to terminate pregnancy. In: Koren G, editor. Maternal-fetal toxicology. 2nd ed. New York: Marcel Dekker Inc., 1994: 727–35

    Google Scholar 

  3. Barton JR, Prevost RR, Wilson DA, et al. Nifedipine pharmacokinetics and pharmacodynamics during the immediate postpartum period in patients with pre-eclampsia. Am J Obstet Gynecol 1991; 165: 951–4

    PubMed  CAS  Google Scholar 

  4. Rogers RC, Sibai BM, Whybrew WD. Labetolol pharmacokinetics in pregnancy-induced hypertension. Am J Obstet Gynecol 1990; 162(2): 362–6

    PubMed  CAS  Google Scholar 

  5. Wilson JT. Determinants and consequences of drug excretion in breast milk. Drug Metab Rev 1983; 14: 619–52

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pharmacokinetic changes during pregnancy and postpartum is of minor importance for most drugs. Drugs Ther. Perspect 12, 8–10 (1998). https://doi.org/10.2165/00042310-199812100-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199812100-00003

Search

Navigation